Search Results 131-140 of 16994 for pharmacogenetics
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
Pharmacogenetic testing (such as cytochrome P450 2D6 and 2C19, serotonin transporter gene); Transcranial magnetic stimulation; Psychotherapy techniques (such ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Overview Tab Title Description Study type Observational Study IDs Study type Observational Describes the nature of a clinical study.
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...
The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using ...
About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...
Efforts are ongoing to identify response biomarkers by applying multiple omics. This includes genomics, transcriptomics, epigenomics, metabolomics and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.